Predicting survival and the role of androgen suppressive therapy (AST): Radiation therapy oncology group (RTOG) phase III randomized prostate cancer trials

Author(s):  
Mack Roach ◽  
Jiandong Lu ◽  
Miljenko V. Pilepich ◽  
Sucha O. Asbell ◽  
Mohammed Mohuidden ◽  
...  
2003 ◽  
Vol 169 (1) ◽  
pp. 245-250 ◽  
Author(s):  
MACK ROACH ◽  
JIANDONG LU ◽  
MILJENKO V. PILEPICH ◽  
SUCHA O. ASBELL ◽  
MOHAMMED MOHIUDDIN ◽  
...  

2003 ◽  
pp. 245-250 ◽  
Author(s):  
MACK ROACH ◽  
JIANDONG LU ◽  
MILJENKO V. PILEPICH ◽  
SUCHA O. ASBELL ◽  
MOHAMMED MOHIUDDIN ◽  
...  

1999 ◽  
Vol 161 (3) ◽  
pp. 864-868 ◽  
Author(s):  
MACK ROACH ◽  
JIANDONG LU ◽  
MILJENKO V. PILEPICH ◽  
SUCHA O. ASBELL ◽  
MOHAMMED MOHIUDDIN ◽  
...  

2011 ◽  
Vol 20 (6) ◽  
pp. 1317-1325 ◽  
Author(s):  
Kevin Lee Du ◽  
Kyounghwa Bae ◽  
Benjamin Movsas ◽  
Yan Yan ◽  
Charlene Bryan ◽  
...  

2016 ◽  
Vol 195 (4S) ◽  
Author(s):  
Erik N. Mayer ◽  
Jonathan D. Tward ◽  
Sara Lenherr ◽  
James M. Hotaling ◽  
William O. Brant ◽  
...  

2006 ◽  
Vol 9 (S1) ◽  
pp. 411-418
Author(s):  

This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by Radiation therapy Oncology group (RTOG). Clinical trials include: RTOG 9804: Phase III trial of observation ± tamoxifen versus RT ± tamoxifen for good risk duct carcinoma in-situ(DCIS) of the female breast.NSABP B-39/RTOG 0413: A randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) for women with stage 0, I, or II breast cancer.A phase II trial to evaluate three dimensional conformal radiation therapy (3D-RT) confined to the region of the lumpectomy cavity for stage I and II breast carcinoma.


Sign in / Sign up

Export Citation Format

Share Document